Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.
about
Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal CellsDaily Eating Patterns and Their Impact on Health and Disease.Extrapancreatic effects of incretin hormones: evidence for weight-independent changes in morphological aspects and oxidative status in insulin-sensitive organs of the obese nondiabetic Zucker rat (ZFR).C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis.A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway
P2860
Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Potential roles of glucagon-li ...... alcoholic fatty liver disease.
@ast
Potential roles of glucagon-li ...... alcoholic fatty liver disease.
@en
type
label
Potential roles of glucagon-li ...... alcoholic fatty liver disease.
@ast
Potential roles of glucagon-li ...... alcoholic fatty liver disease.
@en
prefLabel
Potential roles of glucagon-li ...... alcoholic fatty liver disease.
@ast
Potential roles of glucagon-li ...... alcoholic fatty liver disease.
@en
P2860
P356
P1476
Potential roles of glucagon-li ...... alcoholic fatty liver disease.
@en
P2860
P304
P356
10.3748/WJG.V20.I27.9090
P407
P50
P577
2014-07-01T00:00:00Z